Track topics on Twitter Track topics that are important to you
FOUNTAIN VALLEY, Calif., Aug. 2, 2017 /PRNewswire/ -- Hyundai Hope On Wheels® today announced the expansion of its Hyundai Quantum Award grant program, which is aimed at increasing the scientific understanding of pediatric cancers with poor prognosis and outcomes.
This year, Hope On Wheels has committed $3 million to fund three (3) Hyundai Quantum Awards in the amount of $1 million each. The organization has announced it will add a new category - The Hyundai Quantum Collaboration Award, which will include one (1) in the amount of $2.5 million. The Quantum Collaboration Award is added to encourage collaboration between two or more pediatric cancer institutions in hopes of having a greater impact on the field of study.
"The cure rate for pediatric cancer is 80 percent, and we are proud to support the ongoing progress that doctors and researchers nationwide have made since Hyundai joined the fight 19 years ago," said Scott Fink, chairman, Hyundai Hope On Wheels Board of Directors. "However, for many pediatric cancers, there remain poor prognosis and outcomes, and research understanding of these cancers is limited. Given recent advancement in technology and therapeutic option, we hope the Hyundai Quantum and Hyundai Collaboration Awards, will aid the field to make major leaps and to better treat options and ultimately cures to these high-risk cancers."
The Hyundai Quantum and The Hyundai Quantum Collaboration Awards are focused on research with four specific pediatric cancer types: 1) central nervous system (CNS) tumors, 2) metastatic pediatric solid tumors, 3) pediatric myeloid leukemia's and 4) pediatric osteosarcomas. The goal is to pursue innovative research that is translational in nature, and that has the potential to impact childhood cancer diagnosis and treatment. Children's Oncology Group (COG) member-institutions are invited to submit a proposal for consideration for one of these grant categories. Selected proposals will be peer reviewed by a committee of leading pediatric cancer oncologist. Application instructions may be found on proposalCENTRAL or visiting our website, HyundaiHopeOnWheels.org.
"One of our corporate values at Hyundai is to help make things Better. In particular, we are committed to pediatric cancer research and our goal to bring hope to all children faced with this disease," said Jerry Flannery, President and CEO of Hyundai Motor America. "While there has been much progress in the survival rates over the past 40 years, for many pediatric cancers the treatment options and standards of care have shown little progress. We believe that children deserve to grow up in a world free of pediatric cancer. Working in partnership with the pediatric oncology research community, we are making new research funds available to target these high-risk pediatric cancers. With our previously announced sixty-eight grant winners for this year, the Hyundai Quantum will support our goal, to end childhood cancer."
The Hyundai Hope On Wheels program has supported pediatric cancer research in the U.S. since 1998. A leading group of pediatric oncologists makes up the organization's Medical Advisory Committee and assist in the peer-review vetting of grant proposals. Dr. David Poplack, director, Texas Children's Cancer Center at Texas Children's Hospital, and member of the HHOW Medical Advisory Committee says, "The Hyundai Quantum and Hyundai Quantum Collaboration Awards are exciting to the field at this critical time. Throughout my career we have seen major advances in pediatric cancer outcomes, but some pediatric cancers continue to be major therapeutic challenges. These additional funds offered by Hyundai represent a substantial amount of money that will help to increase the focus on research for high risk pediatric cancers and potentially will lead to exciting breakthroughs where they're needed the most!"
Hope On Wheels distributed a request for proposal (RFP) to eligible Children's Oncology Group (COG) member institutions nationwide and is now accepting letters of intent (LOI). LOIs are due by Friday, September 1, 2017. Hyundai Quantum and Hyundai Quantum Collaboration Award winners will be publicly announced on March 29, 2018 during the annual HHOW program launch in New York City.
To learn more about the Hyundai Quantum Award and other Hope On Wheels grant programs, please visit HyundaiHopeOnWheels.org/grant-programs.
For more information about Hyundai Hope On Wheels and to view a complete list of this year's grant winners, please visit HyundaiHopeOnWheels.org/research. Follow us on Facebook, Twitter or Instagram at facebook.com/HyundaiHopeOnWheels, twitter.com/HopeOnWheels or instagram.com/HyundaiHopeOnWheels.
HYUNDAI HOPE ON WHEELS
Hyundai Hope On Wheels® is a 501(c)(3) non-profit organization that is committed to finding a cure for childhood cancer. Launched in 1998, Hyundai Hope On Wheels provides grants to eligible institutions nationwide that are pursuing life-saving research and innovative treatments for the disease. Hyundai Hope on Wheels is one of the largest non-profit funders of pediatric cancer research in the country. Primary funding for Hyundai Hope On Wheels comes from Hyundai Motor America and its more than 835 U.S. dealers. Since its inception, Hyundai Hope On Wheels has awarded more than $130 million towards childhood cancer research in pursuit of a cure.
HYUNDAI MOTOR AMERICAHyundai Motor America, headquartered in Fountain Valley, Calif., is a subsidiary of Hyundai Motor Company of Korea. Hyundai vehicles are distributed throughout the United States by Hyundai Motor America and are sold and serviced through 835 dealerships nationwide. All new Hyundai vehicles sold in the U.S. are covered by the Hyundai Assurance program, which includes a 5-year/60,000-mile fully-transferable new vehicle limited warranty, Hyundai's 10-year/100,000-mile powertrain limited warranty and five years of complimentary Roadside Assistance.
View original content with multimedia:http://www.prnewswire.com/news-releases/hyundai-hope-on-wheels-announces-expansion-of-its-pediatric-cancer-research-grant--the-hyundai-quantum-and-hyundai-quantum-collaboration-awards-300498188.html
SOURCE Hyundai Hope On WheelsNEXT ARTICLE
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...